{"id":2301,"date":"2026-09-16T13:59:01","date_gmt":"2026-09-16T13:59:01","guid":{"rendered":"https:\/\/www.arcgroup.io\/west-london\/?post_type=event&p=2301"},"modified":"2026-09-17T09:54:37","modified_gmt":"2026-09-17T09:54:37","slug":"creative-disruption-forum-latest-and-future-technologies-impacting-life-sciences","status":"publish","type":"event","link":"https:\/\/www.arcgroup.io\/west-london\/events\/creative-disruption-forum-latest-and-future-technologies-impacting-life-sciences\/","title":{"rendered":"Creative Disruption Forum: Latest and Future Technologies"},"content":{"rendered":"
\n

Creative Disruption Forum: Latest and Future Technologies<\/h1>
\n \n <\/use>\n <\/svg>\n
\n ARC West London Manbre Road London W6 9RH <\/div>\n
\n \n 18th Nov 2026 09:00AM – 16:30PM <\/div>\n <\/div>\n<\/section>\n\n\n\n
\n
\n \n \n \n <\/picture>\n\n <\/div>\n<\/section>\n\n\n\n

Overview<\/p>\n\n\n\n

This thought-leader discussion is about technologies that are disrupting the life sciences and health innovation sectors today & tomorrow<\/p>\n\n\n\n

About the Event<\/strong><\/h2>\n\n\n\n

The Creative Disruption Forum<\/strong> is a high-level, interactive gathering built for executive leaders, senior researchers, startup founders, and biotech investors.<\/p>\n\n\n\n

The Quantum Horizon Meets Real-World Science<\/strong><\/p>\n\n\n\n

We are witnessing a transformative shift in health innovation. While emerging paradigms like quantum computing promise to fundamentally redefine how we process biological complexity in the future, biopharma leaders today need actionable, deployable technologies to de-risk pipelines, accelerate drug discovery, and improve clinical outcomes now.<\/p>\n\n\n\n

The Latest & Future Technologies Impacting Health Innovation and Life Sciences bridges the gap between tomorrow\u2019s deep-tech horizons and today\u2019s high-impact biological and computational breakthroughs. Hosted at ARC West London as a flagship London Life Sciences Week event, this interactive forum brings together biopharma executives, tech bio founders, investors, and academic leaders for unscripted, Chatham House Rules discussions on what is genuinely working, where the bottlenecks lie, and how to build scalable healthcare solutions.<\/p>\n\n\n\n

From physical molecule-to-protein target engagement (such as CETSA\u00ae platforms) and human-relevant New Approach Methodologies (NAMs) to real-world AI applications in lead optimization, this event delivers an unfiltered “boots on the ground” look at modern translational science.<\/p>\n\n\n\n

Why You Should Attend:<\/strong><\/p>\n\n\n\n

Ground Your Strategy in Real-World Tech: Move beyond theoretical hype to evaluate proven technologies transforming R&D pipelines today\u2014including next-gen sequencing (NGS), advanced cell & gene therapies, and biophysical target-engagement assays.<\/p>\n\n\n\n

De-Risk Your Clinical Pipeline: Discover how New Approach Methodologies (NAMs), organ-on-a-chip systems, and cellular shift assays are replacing legacy models, reducing Phase II\/III failure rates, and delivering more efficacious molecules into the clinic.<\/p>\n\n\n\n

Unfiltered “Boots on the Ground” Insights: Hear directly from SME CEOs and biopharma R&D directors on integrating AI into discovery pipelines\u2014sharing candid case studies on what works, what has failed, and how to avoid costly missteps.<\/p>\n\n\n\n

Connect Across the West Tech District: Engage directly with key anchors across West London\u2019s innovation ecosystem, including Imperial College London, White City Innovation District, Paddington Life Sciences, Nexus, and ARC Group.<\/p>\n\n\n\n

Actionable Peer-to-Peer Workshops: Participate in interactive afternoon breakout sessions designed to co-create practical strategies for scaling deep-tech venture navigating regulatory pathways for NAMs, and optimizing R&D data.<\/p>\n\n\n\n

Who Should Attend:<\/strong><\/p>\n\n\n\n